Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Rheumatology"
DOI: 10.1007/s10067-020-05184-3
Abstract: Individuals susceptible to infection with coronavirus 2019 (COVID-19) represent heterogeneous populations presenting a large risk spectrum. Risk stratification is critical to define clinically relevant subpopulations to more accurately target screening, prevention, and therapeutic interventions and… read more here.
Keywords: infected covid; risk; developing severe; risk developing ... See more keywords